Skip to main content
. 2022 Apr 3;14(4):783. doi: 10.3390/pharmaceutics14040783

Figure 8.

Figure 8

Comparative radical scavenging activity (RSA) of the optimized AGN-PLHNPs and free AGN through (A) DPPH assay and (B) ABTS assay. * Significant to free AGN and ** highly significant to free AGN. (p < 0.05 considered as significant difference).

HHS Vulnerability Disclosure